Actisite
FDA Approves Dotarem, a New MRI Agent »
"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Actisite
Please Note: This Brand Name drug is no longer available in the US.(Generic versions may still be available.)
PATIENT INFORMATION
When Actisite® (tetracycline periodontal) fiber is in place, patients should avoid actions that may dislodge the fiber. Patients should receive the following instructions:
- Do not chew hard, crusty, or sticky foods.
- Do not brush or floss near any treated areas. (Continue to clean other teeth.)
- Do not engage in any other hygienic practices that could potentially dislodge the fibers.
- Do not probe at the treated area with tongue or fingers.
- Notify the dentist promptly if the fiber is dislodged or falls out before the scheduled recall visit, or if pain or swelling or other problems occur.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Actisite Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
